Literature DB >> 25950238

Long-Term Outcomes of Total Parathyroidectomy With or Without Autoimplantation for Hyperparathyroidism in Chronic Kidney Disease: A Meta-Analysis.

Xiaoyan Jia1, Rong Wang2, Chengyin Zhang3, Meiyu Cui1, Dongmei Xu1.   

Abstract

The aim of the present study was to compare total parathyroidectomy without autotransplantation (TPTX) versus total parathyroidectomy with autotransplantation (TPTX + AT) for renal hyperparathyroidism (RHPT) with respect to long-term outcomes. A literature search was undertaken using Medline and EMBASE from inception to December 2013. Data were analyzed using Review Manager version 5.0. A total of seven cohort studies comprising 931 patients were identified. Compared with TPTX + AT, patients in the TPTX group have lower "recurrence" (odds ratio (OR) 0.08, confidence interval (CI) 0.03 to 0.21; P < 0.00001), lower "recurrence or persistence"(OR 0.11, 95% CI 0.05 to 0.25; P < 0.00001), lower "requiring reoperation because of recurrence or persistence" (OR 0.17, CI 0.06 to 0.54; P = 0.002), and higher "hypoparathyroidism" (OR 2.97, CI 1.09 to 8.08; P = 0.03). None of the patients in these seven studies were recorded as having severe hypocalcemia or adynamic bone disease. Compared with TPTX + AT, TPTX is associated with lower "requiring reoperation because of recurrence or persistence" and without severe hypocalcemia or adynamic bone disease.
© 2015 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Entities:  

Keywords:  Chronic kidney disease; Outcomes; Parathyroidectomy; Renal hyperparathyroidism

Mesh:

Year:  2015        PMID: 25950238     DOI: 10.1111/1744-9987.12310

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  7 in total

1.  Parathyroid Hormone Reduction Predicts Transient Hypocalcemia after Total Thyroidectomy: A Single-Center Prospective Study.

Authors:  Kangnan Mo; Jinbiao Shang; Kejing Wang; Jialei Gu; Peng Wang; Xilin Nie; Wendong Wang
Journal:  Int J Endocrinol       Date:  2020-08-01       Impact factor: 3.257

2.  Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol.

Authors:  Jiunn Wong; Wing Hang Fu; Ee Lim Amy Lim; Chung Fai Jeremy Ng; Hui Lin Choong
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

3.  PTH monitoring after total parathyroidectomy with forearm auto-transplantation: potential for spuriously high levels from grafted forearm.

Authors:  Diana Khalil; Paul D Kerr
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-06-23

4.  Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience.

Authors:  Claudio Casella; Alessandro Galani; Luigi Totaro; Silvia Ministrini; Silvia Lai; Mira Dimko; Nazario Portolani
Journal:  Int J Endocrinol       Date:  2018-07-09       Impact factor: 3.257

5.  Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis.

Authors:  Pei Wu; Pengliang Wang; Bin Ma; Songcheng Yin; Yuen Tan; Wenbin Hou; Zhenning Wang; Huimian Xu; Zhi Zhu
Journal:  Cancer Manag Res       Date:  2018-10-26       Impact factor: 3.989

6.  Therapeutic experience of severe and recurrent secondary hyperparathyroidism in a patient on hemodialysis for 18 years: A case report.

Authors:  Mingwen Zhu; Zongming Zhang; Fangcai Lin; Jieping Miao; Pei Wang; Chong Zhang; Hongwei Yu; Hai Deng; Zhuo Liu; Limin Liu; Baijiang Wan; Haiyan Yang; Mengmeng Song; Yue Zhao; Nan Jiang; Zichao Zhang; Zhenya Zhang; Lijie Pan
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

Review 7.  Total parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: systematic review and meta-analysis.

Authors:  Changjia Li; Liang Lv; Hongqiao Wang; Xufu Wang; Bangxu Yu; Yan Xu; Xiaobin Zhou; Yanbing Zhou
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.